Login or Sign Up
Eris Lifesciences Ltd. Corporate Actions
15:57 Jul 18
Eris Lifesciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Eris Lifesciences Ltd.
Industry Pharmaceuticals
15:57 Jul 18
Quality
55/100
High Financial Strength
Valuation
32/100
Mid Valuation
Technical
69/100
Technically Moderately Bullish
Strength
7
Weakness
8
Opportunity
1
Threats
0
0.42 %
Dividend Yield
24.01K
Market Cap (Cr)
59.14
RSI
54.83 %
Promoter Holding
12.15 %
Net Profit Margin
| Ex-Date | Type | Description | Record Date | Ratio | Dividend Type |
|---|---|---|---|---|---|
| 13-Feb-2025 | Dividend | 7.35/share@735.00% | 13-Feb-2025 | 735.00 | Interim |
| 11-Aug-2022 | Dividend | 7.35/share@735.00% | 16-Aug-2022 | 735.00 | Interim |
| 05-Aug-2021 | Dividend | 6.01/share@601.00% | 06-Aug-2021 | 601.00 | Interim |
| 13-Aug-2020 | Dividend | 5.50/share@550.00% | 14-Aug-2020 | 550.00 | Interim |
| 19-Mar-2020 | Dividend | 2.87/share@287.00% | 20-Mar-2020 | 287.00 | Interim |
| 12-Jul-2019 | Tender Offer | Ratio | - | - | - |
Download Our App On:
Back
OTP sent to your mobile number/email. Please enter it below to verify.
